Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
12/2007
12/12/2007CN101087768A Thrombopoietin activity modulating compounds and methods
12/12/2007CN101085041A Total alkaloid of lotus leaves extraction and its preparation method
12/12/2007CN100354265C Pharmaceutical compounds
12/11/2007US7307088 Substituted anthranilic amide derivatives and methods of use
12/11/2007US7307086 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/06/2007US20070281363 Luminescent compounds
12/05/2007EP1861379A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
12/05/2007EP1861373A2 Processes for preparing morphinans and intermediates thereof
12/05/2007EP1860942A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/04/2007US7304159 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
11/2007
11/29/2007US20070276140 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007CA2651732A1 Intracellular kinase inhibitors
11/28/2007EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2007104680B1 Polymerisation of ethylene and alpha-olefins with imino-quinolinol complexes
11/22/2007WO2007076116A3 Intermediates for preparing solifenacin
11/22/2007WO2007075783A3 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
11/22/2007WO2006121719A3 Soluble epoxide hydrolase inhibitors and methods of using same
11/22/2007US20070270460 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
11/21/2007EP1857444A1 Tetrahydroisoquinoline compound and medicinal use thereof
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007CN100349888C Medicine compound
11/15/2007WO2007109160A9 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
11/15/2007WO2007098608A8 Chiral ligands, their preparation and uses thereof in assymetric reactions
11/15/2007US20070265348 Therapeutic guanidines
11/15/2007US20070265315 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
11/15/2007US20070265301 Dpp-IV Inhibitors
11/15/2007US20070265300 Pyridine Derivatives of Alkyl Oxindoles as 5-Ht7 Receptor Active Agents
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007DE102006046922B3 Biofilm-hemmende Wirkung sowie anti-infektive Aktivität N,C-verknüpfter Arylisochinoline, deren pharmazeutischen Zusammensetzung und deren Verwendung Biofilm-inhibitory effect and anti-infective activity of N, C-linked Arylisochinoline whose pharmaceutical composition and the use thereof
11/14/2007EP1399423B1 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007CN100348583C Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof
11/13/2007US7294635 Substituted isoquinolinones
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
11/08/2007US20070259871 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/07/2007EP1852421A1 Process for production of 4-fluoroisoquinoline-5-sulfonyl halide or salt thereof
11/07/2007CN100347160C Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
11/06/2007US7291619 Melanocortin receptor agonists
11/01/2007US20070254942 1S)-Cyclopropanecarboxylic acid {7-chloro-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}amide, which may further contain an anticancer agent or an antiinflammatory agent; treating atopic dermatitis, Crohn's disease, and colon cancer
10/2007
10/31/2007EP1848707A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
10/31/2007EP1603923B9 Metal complexes
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/30/2007US7288549 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/25/2007WO2006021964A3 Novel crystalline forms of nelfinavir mesylate
10/25/2007US20070249838 Deprotonation of pyridine, 2-fluoropyridine, or methoxypyridine with (trimethylsilylmethyl)lithium or neopentyllithium; industrial scale; direct deprotonation and minimized nucleophilic attack on an azaaromatic compound results in improved yields and simplified purification schemes for the deprotonation
10/25/2007US20070249665 1-aryl-4-substituted isoquinolines
10/25/2007US20070249658 Pyrrolo[3,2-C]Pyridine Deriatives and Processes for the Preparation Thereof
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/24/2007EP1567010B1 Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285565 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-trifluoromethylphenoxy)1-aminoisoquinoline; and 3-hydroxycarbonyl-2-(4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenoxynaphthalene; highly selective
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007WO2007115410A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007115403A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007014263A3 Octahydroisoquinoline compounds as opioid receptor modulators
10/18/2007US20070244327 Opiate Intermediates and Methods of Synthesis
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244156 Sulfonylamino-acetic acid derivatives
10/18/2007US20070244151 Opiate Intermediates and Methods of Synthesis
10/18/2007US20070244098 Dual Small Molecule Inhibitors of Cancer and Angiogenesis
10/18/2007US20070241065 Extraction of Alkaloids for Opium
10/18/2007CA2652109A1 Compositions and methods for modulating gated ion channels
10/18/2007CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007CA2648323A1 Substituted ring fused azines and their use in cancer therapy
10/17/2007EP1844045A1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
10/17/2007EP1742909A4 Anionic-sweetener-based ionic liquids and methods of use thereof
10/17/2007CN101056635A Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/16/2007USRE39888 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007CN101052622A Opiate intermediates and methods of synthesis
10/09/2007US7279578 Use as orexin receptor antagonists, depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis; depressive neurosis; anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; schizophrenia; manic depression; delerium
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/04/2007WO2007112347A1 Dipeptidyl peptidase inhibitors
10/04/2007US20070232654 Novel Compounds and Compositions as Cathepsin Inhibitors
10/03/2007EP1838315A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 119